The treatment with RA serum significantly increased the expression of CD16, promoting a pronounced expansion of CD14++CD16+ monocyte subset after 96 h (p ≤ 0.05; Figures 9A–C). The gene discussed is CD14; the disease is rheumatoid arthritis.